{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:11:48Z","timestamp":1793157108278,"version":"4.5.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Recent studies increasingly support a role for autoantibodies in selected chronic pain disorders. This review examines current evidence linking autoantibodies to nociceptive sensitisation and neuroimmune dysfunction across these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Experimental and clinical evidence links autoantibodies to altered neuronal excitability, neuroimmune activation, and pain hypersensitivity, particularly within the dorsal root ganglion and spinal sensory circuits. Emerging work further suggests that pathogenicity and treatment responsiveness depend on factors beyond antibody specificity alone, including tissue injury, inflammatory context, and downstream immune signalling mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Autoimmune pain disorders appear to comprise biologically heterogeneous neuroimmune syndromes in which dorsal root ganglia and anatomically connected sensory pathways emerge as recurring sites of sensitisation. Pathogenicity depends not only on antibody specificity but also on tissue context and downstream neuroimmune mechanisms, supporting the development of more targeted and mechanism-based therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/spc.0000000000000820","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:00:14Z","timestamp":1783418414000},"page":"121-127","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Recent advances in autoantibody-mediated pain"],"prefix":"10.1097","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6120-9342","authenticated-orcid":false,"given":"Adham","family":"Farah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Dawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"105999","DOI":"10.1016\/j.jbspin.2025.105999","article-title":"Immune control of pain","volume":"93","author":"Paolini","year":"2026","journal-title":"Joint Bone Spine"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"101\u2013104","DOI":"10.1016\/j.molmed.2025.07.003","article-title":"Autoantibodies as drivers of neuropathic pain","volume":"32","author":"Farah","year":"2026","journal-title":"Trends Mol Med"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"key":"R4-20260803","doi-asserted-by":"crossref","first-page":"1828\u20131840","DOI":"10.1097\/j.pain.0000000000002881","article-title":"Fibromyalgia patients with elevated levels of anti-satellite glia cell immunoglobulin G antibodies present with more severe symptoms","volume":"164","author":"Krock","year":"2023","journal-title":"Pain"},{"key":"R5-20260803","doi-asserted-by":"crossref","first-page":"e11413","DOI":"10.1002\/advs.202511413","article-title":"Pathogenic role of FGFR3 autoantibodies in small fiber neuropathy","volume":"13","author":"Salih","year":"2026","journal-title":"Adv Sci"},{"key":"R6-20260803","doi-asserted-by":"crossref","first-page":"4016\u20134029","DOI":"10.1093\/brain\/awaf321","article-title":"A\u03b2 low-threshold mechanoreceptors contribute to sensory abnormalities in fibromyalgia","volume":"148","author":"Israel","year":"2025","journal-title":"Brain"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"683\u2013690","DOI":"10.1002\/ana.26189","article-title":"Leucine-rich glioma-inactivated 1 versus contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons","volume":"90","author":"Ramanathan","year":"2021","journal-title":"Ann Neurol"},{"key":"R8-20260803","doi-asserted-by":"crossref","first-page":"e200160","DOI":"10.1212\/NXI.0000000000200160","article-title":"Immunotherapy-responsive neuropathic pain and allodynia in a patient with glycine receptor autoantibodies: A case report","volume":"10","author":"Soleimani","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R9-20260803","doi-asserted-by":"crossref","first-page":"578734","DOI":"10.1016\/j.jneuroim.2025.578734","article-title":"Neuropathic pain in CASPR2 antibody disease spectrum: a systematic review","volume":"408","author":"Cornacchini","year":"2025","journal-title":"J Neuroimmunol"},{"key":"R10-20260803","doi-asserted-by":"crossref","first-page":"521\u2013528","DOI":"10.1002\/ana.27177","article-title":"Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease","volume":"97","author":"Ceronie","year":"2025","journal-title":"Ann Neurol"},{"key":"R11-20260803","doi-asserted-by":"crossref","first-page":"e905","DOI":"10.1097\/PR9.0000000000000905","article-title":"Autoimmune regulation of chronic pain","volume":"6","author":"Lacagnina","year":"2021","journal-title":"Pain Rep"},{"key":"R12-20260803","doi-asserted-by":"crossref","first-page":"79\u201392","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI 1\/ CASPR 2- I g G \u2013positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"R13-20260803","doi-asserted-by":"crossref","first-page":"2736\u20132744","DOI":"10.1007\/s00415-024-12224-4","article-title":"Different pain phenotypes are associated with anti-Caspr2 autoantibodies","volume":"271","author":"Greguletz","year":"2024","journal-title":"J Neurol"},{"key":"R14-20260803","doi-asserted-by":"crossref","first-page":"e200423","DOI":"10.1212\/NXI.0000000000200423","article-title":"Neuropathic pain and distinct CASPR2 autoantibody IgG subclasses drive neuronal hyperexcitability","volume":"12","author":"Habib","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R15-20260803","doi-asserted-by":"crossref","first-page":"266\u2013278","DOI":"10.1016\/j.bbi.2024.08.027","article-title":"Human cerebrospinal fluid monoclonal CASPR2 autoantibodies induce changes in electrophysiology, functional MRI, and behavior in rodent models","volume":"122","author":"van Hoof","year":"2024","journal-title":"Brain Behav Immun"},{"key":"R16-20260803","doi-asserted-by":"crossref","first-page":"248\u2013250","DOI":"10.1016\/j.clinph.2018.11.017","article-title":"Neuropathic pain, dysautonomia, and nerve hyperexcitability: Expanding the spectrum of LGI1 autoimmunity","volume":"130","author":"Berzero","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"R17-20260803","article-title":"A role for leucine-rich, glioma-inactivated 1 in regulating pain sensitivity","author":"Farah","year":"2024","journal-title":"Brain"},{"key":"R18-20260803","doi-asserted-by":"crossref","first-page":"e200096","DOI":"10.1212\/NXI.0000000000200096","article-title":"Comparative effects of domain-specific human monoclonal antibodies against lgi1 on neuronal excitability","volume":"10","author":"Sell","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R19-20260803","doi-asserted-by":"crossref","first-page":"877\u2013893","DOI":"10.1515\/revneuro-2024-0027","article-title":"The role of antibodies in small fiber neuropathy: a review of currently available evidence","volume":"35","author":"Morelli","year":"2024","journal-title":"Rev Neurosci"},{"key":"R20-20260803","doi-asserted-by":"crossref","first-page":"1254854","DOI":"10.3389\/fnmol.2023.1254854","article-title":"A role for pathogenic autoantibodies in small fiber neuropathy?","volume":"16","author":"Daifallah","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"R21-20260803","doi-asserted-by":"crossref","first-page":"e1028","DOI":"10.1212\/NXI.0000000000001028","article-title":"Antiplexin D1 antibodies relate to small fiber neuropathy and induce neuropathic pain in animals","volume":"8","author":"Fujii","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R22-20260803","doi-asserted-by":"crossref","first-page":"512\u2013515","DOI":"10.1002\/mus.26748","article-title":"Cryptogenic small-fiber neuropathies: serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3","volume":"61","author":"Levine","year":"2020","journal-title":"Muscle Nerve"},{"key":"R23-20260803","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-025-03557-6","article-title":"Interferon-induced GTP-binding protein MX1 drives hyperexcitability in peripheral nerves: a novel mechanism in small fiber neuropathy","volume":"22","author":"Chan","year":"2025","journal-title":"J Neuroinflammation"},{"key":"R24-20260803","article-title":"Expression of Fibroblast Growth Factor Receptor 3 (FGFR3) in the Human Peripheral Nervous System: Implications for the Putative Pathogenic Role of FGFR3 Autoantibodies in Neuropathy","author":"Chamessian","year":"2025","journal-title":"bioRxiv"},{"key":"R25-20260803","doi-asserted-by":"crossref","first-page":"184\u2013196","DOI":"10.1097\/CND.0000000000000485","article-title":"Effectiveness of IVIG on non\u2013length-dependent skin biopsies in small fiber neuropathy with plexin D1, trisulfated heparin disaccharide, and fibroblast growth factor receptor 3 autoantibodies","volume":"25","author":"Zeidman","year":"2024","journal-title":"J Clin Neuromuscul Dis"},{"key":"R26-20260803","doi-asserted-by":"crossref","first-page":"363\u2013370","DOI":"10.1002\/mus.27745","article-title":"A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies","volume":"67","author":"Gibbons","year":"2023","journal-title":"Muscle Nerve"},{"key":"R27-20260803","doi-asserted-by":"crossref","first-page":"593\u2013606","DOI":"10.1002\/acn3.70232","article-title":"Nationwide survey of atopic myelitis and plexin D1-immunoglobulin G-related pain","volume":"13","author":"Kira","year":"2026","journal-title":"Ann Clin Transl Neurol"},{"key":"R28-20260803","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.3390\/ijms25115922","article-title":"Inflammation, autoimmunity, and infection in fibromyalgia: a narrative review","volume":"25","author":"Paroli","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R29-20260803","doi-asserted-by":"crossref","first-page":"e144201","DOI":"10.1172\/JCI144201","article-title":"Passive transfer of fibromyalgia symptoms from patients to mice","volume":"131","author":"Goebel","year":"2021","journal-title":"J Clin Invest"},{"key":"R30-20260803","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1097\/j.pain.0000000000003629","article-title":"Postacute COVID-19 syndrome and fibromyalgia syndrome are associated with anti-satellite glial cell IgG serum autoantibodies but only fibromyalgia syndrome serum-IgG is pronociceptive","volume":"166","author":"Berwick","year":"2025","journal-title":"Pain"},{"key":"R31-20260803","doi-asserted-by":"crossref","first-page":"1922\u20131933","DOI":"10.1097\/j.pain.0000000000003535","article-title":"Autoantibodies in patients with fibromyalgia syndrome","volume":"166","author":"Seefried","year":"2025","journal-title":"Pain"},{"key":"R32-20260803","doi-asserted-by":"crossref","first-page":"e2211631120","DOI":"10.1073\/pnas.2211631120","article-title":"Neutrophils infiltrate sensory ganglia and mediate chronic widespread pain in fibromyalgia","volume":"120","author":"Caxaria","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"R33-20260803","doi-asserted-by":"crossref","DOI":"10.1113\/JP289612","article-title":"Mechanical sensitization of sensory afferents after passive transfer of fibromyalgia IgG","author":"Israel","year":"2026","journal-title":"J Physiol"},{"key":"R34-20260803","article-title":"The sensitising effect of IgG in fibromyalgia syndrome is mediated by Mrgprb2 in mast cells","author":"Sanchez","year":"2025","journal-title":"bioRxiv"},{"key":"R35-20260803","doi-asserted-by":"crossref","first-page":"371\u2013387","DOI":"10.1016\/j.bbi.2025.01.015","article-title":"Reducing IgG accumulation via neonatal Fc receptor (FcRn) blockade relieves neuropathic pain","volume":"125","author":"Fiore","year":"2025","journal-title":"Brain Behav Immun"},{"key":"R36-20260803","doi-asserted-by":"crossref","first-page":"2804\u20132817","DOI":"10.1097\/j.pain.0000000000003734","article-title":"Autoreactive immunoglobulin G levels and Fc receptor \u03b3 subunit upregulation drive mechanical allodynia after nerve constriction or crush injury","volume":"166","author":"Fiore","year":"2025","journal-title":"Pain"},{"key":"R37-20260803","doi-asserted-by":"crossref","first-page":"13067\u201313076","DOI":"10.1073\/pnas.1820168116","article-title":"Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1\u2013induced mechanisms","volume":"116","author":"Helyes","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"R38-20260803","doi-asserted-by":"crossref","first-page":"299\u2013308","DOI":"10.1016\/j.pain.2013.10.011","article-title":"A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome","volume":"155","author":"T\u00e9kus","year":"2014","journal-title":"Pain"},{"key":"R39-20260803","doi-asserted-by":"crossref","first-page":"2855\u20132865","DOI":"10.1097\/j.pain.0000000000001662","article-title":"Autoantibodies produce pain in complex regional pain syndrome by sensitizing nociceptors","volume":"160","author":"Cuhadar","year":"2019","journal-title":"Pain"},{"key":"R40-20260803","doi-asserted-by":"crossref","first-page":"421\u2013434","DOI":"10.1097\/j.pain.0000000000002725","article-title":"Pronociceptive autoantibodies in the spinal cord mediate nociceptive sensitization, loss of function, and spontaneous pain in the lumbar disk puncture model of chronic back pain","volume":"164","author":"Guo","year":"2023","journal-title":"Pain"},{"key":"R41-20260803","doi-asserted-by":"crossref","first-page":"1519\u20131531","DOI":"10.1097\/j.pain.0000000000003500","article-title":"Autoantibodies cause nociceptive sensitization in a mouse model of degenerative osteoarthritis","volume":"166","author":"Guo","year":"2025","journal-title":"Pain"},{"key":"R42-20260803","doi-asserted-by":"crossref","first-page":"809\u2013816","DOI":"10.1007\/s43440-025-00720-x","article-title":"Blockade of IgG Fc receptors reduces pain after intervertebral disc injury","volume":"77","author":"Shi","year":"2025","journal-title":"Pharmacol Rep"},{"key":"R43-20260803","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41467-023-36257-x","article-title":"A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"R44-20260803","doi-asserted-by":"crossref","first-page":"eadl2922","DOI":"10.1126\/scitranslmed.adj1277","article-title":"B cells drive neuropathic pain\u2013related behaviors in mice through IgG\u2013Fc gamma receptor signaling","volume":"16","author":"Lacagnina","year":"2024","journal-title":"Sci Transl Med"},{"key":"R45-20260803","doi-asserted-by":"crossref","first-page":"1932\u20131949","DOI":"10.1093\/brain\/awac418","article-title":"Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage","volume":"146","author":"Appeltshauser","year":"2023","journal-title":"Brain"},{"key":"R46-20260803","doi-asserted-by":"crossref","first-page":"e200542","DOI":"10.1212\/NXI.0000000000200524","article-title":"High relapse rate in anti-CASPR2 disease","volume":"13","author":"Brand","year":"2026","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SPC.0000000000000820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:00:51Z","timestamp":1785758451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/SPC.0000000000000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000820","relation":{},"ISSN":["1751-4266"],"issn-type":[{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}